Bid price | 31.00 | Open price | 31.30 |
---|---|---|---|
Ask price | 33.00 | Prev close | 32.00 |
High price | 0.00 | Spread | 6.06% |
Low price | 0.00 | Volume | 0 |
Register now for FREE live Mereo Biopharma Group share prices, Mereo Biopharma Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Mereo Biopharma Group Level 2 Data, indepth research tools and investor commentary for Mereo Biopharma Group (MPH) and other London Stock Exchange equities.
Register now for FREE Mereo Biopharma Group share price charts
Name | Mereo Biopharma Group | Epic | MPH |
---|---|---|---|
Sector | n/a | ISIN | GB00BZ4G2K23 |
Activites | n/a | Index | n/a |
Dec.Date | Type | Director | Pos | No. of Shares |
---|---|---|---|---|
05/08/2020 | BUY | Denise Scots-Knight | CEO | 52,815 |
27/11/2019 | BUY | Richard Jones | RES | 26,100 |
25/11/2019 | BUY | Richard Jones | RES | 25,440 |
22/11/2019 | BUY | Anders Ekblom | NED | 50,000 |
14/10/2019 | BUY | Peter Fellner | CH | 1,700 |
RNS Number : 8371G Mereo BioPharma Group plc 30 November 2020 Mereo BioPharma Reminds Market of Key Dates for AIM Delisting London and Redwood City, Calif., November 30, 2020 -...
RNS Number : 0927G Mereo BioPharma Group plc 23 November 2020 Mereo BioPharma Appoints Suba Krishnan, M.D. Senior Vice President of Clinical Development London and Redwood City, Calif.,...
RNS Number : 3530F Mereo BioPharma Group plc 16 November 2020 Mereo BioPharma to Hold Virtual R&D Day on Tuesday, November 24, 2020 London and Redwood City, Calif., November 16, 2020...
More Mereo Biopharma Group Company News >>
Register now for FREE Mereo Biopharma Group company news
Isn't it time EPIC Codes* were allowed to RIP? - MPH was Marchpole ( clothing) -and the Forum-chatter is about that failed company. Let's start a new set of writings about the Pharms Company, currently £2.50 ish ( Dec2016) and about to feature in the January evening ( London) get-together. *...
Marchpole is one of those stocks which have had a really bad time. Boardroom battles, losses, price collapse, profit warnings up the ying yang. Now all of those things seem to be sorted out, new management are getting to grips, new contracts and the price is on the up. So much so that Monday...
Any one know if this company is worth investing in. Have read some info, but would welcome any input.
Register now for FREE Mereo Biopharma Group share price discussions